TheProfitWatch

PPCB - Propanc Biopharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.79 -0.05 (-2.79%) --- -0.01 (-0.51%) 0.03 (1.75%) -0.02 (-1.07%) -0.04 (-2.26%) 0.04 (2.35%) 0.04 (2.35%)

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
81.25
VWAP:
1.74
RVol:
3.593

Events

Period Kind Movement Occurred At
1m Price increase 1m 1.81 +0.04 (+2.26%) Oct 15 09:59
1m Price increase 1m 1.78 +0.02 (+1.14%) Oct 15 09:52
1m Price decrease 1m 1.75 -0.02 (-1.13%) Oct 15 09:43
1m Price decrease 1m 1.74 -0.02 (-1.14%) Oct 15 09:41
1m Price increase 1m 1.77 +0.02 (+1.14%) Oct 15 09:37

Related News